PDMR-521955-158-R4 | Imaging characterization of a metastatic patient derived model of adenocarcinoma pancreas:
DOI: 10.7937/q37d-vh79 | Data Citation Required | 100 Views | Image Collection
| Location | Species | Subjects | Data Types | Cancer Types | Size | Status | Updated | |
|---|---|---|---|---|---|---|---|---|
| Abdomen | Mouse | 20 | MR, SR, Protocol | Pancreatic adenocarcinoma | Clinical | Public, Complete | 2022/08/17 |
Summary
Pre-clinical animal models of spontaneous metastatic cancer are infrequent; the few that exist are resource intensive because determination of the presence of metastatic disease, metastatic burden, and response to therapy normally require multiple timed cohorts with animal sacrifice and extensive pathological examination. We identified and characterized a patient derived xenograft model with metastatic potential, adenocarcinoma pancreas xenograft 521955-158-R4. In this study we performed a detailed imaging characterization (workflow below) of this model, which develops spontaneous lung metastases, details are provided in the attached standard operating procedures. Tumors in half of the mice were resected in the range 200-300 mm3 size; tumors in the other half were allowed to grow until it was necessary to euthanize them because of tumor size. The imaging characteristics of this model (PDMR-521955-158-R4), which is available from the National Cancer Institute Patient-Derived Models Repository (https://pdmr.cancer.gov/), is highly favorable for preclinical research studies of metastatic disease when used in conjunction with non-contrast T2 weighted MRI. Results: Adenocarcinoma pancreas (PDMR-521955-158-R4) Table 1: Penetrance and location of pathological confirmed metastatic lesion(s). # animals in Group # animals that displayed metastasis in MRI and confirmed by Pathology Pathology confirmation of MRI (primary imaging site) Other confirmed Location (s) Mouse ID: MRI with pathology confirmation of metastasis 10 (non-resected) 4 (5 mice were EU due to xenograft size prior to observation of metastases) Lung Lung 2163, 2169, 2171, 2179 10 (resected) 7 Lung Lung (70%) 2160, 2161, 2164, 2170, 2172, 2176, 2178 Percent penetrance with respect to the average time-to-metastasis for non-resected (time from implant: 10.7 ± 1.8 weeks) and resected (time from tumor resection: 5.3 ± 1.1 weeks) cohorts. PET/CT Characterization of the primary tumor: Baseline PET (SOP attached) were performed when tumor reached an approximate 200 mm3. Average SUVmax values (n=6) were calculated; [18F]FDG: 2.3 ± 0.8 and [18F]FLT: 2.4 ± 0.4. Conclusion: Good metastatic model with 40% penetrance un-resected and 70% with planned early resection. Metastases are well observed on T2 MRI imaging allowing non-invasive evaluation in treatment trials.
Para-vertebral muscle (50%)
Nodal disease (10%)
Data Access
Version 1: Updated 2022/08/17
| Title | Data Type | Format | Access Points | Subjects | License | |||
|---|---|---|---|---|---|---|---|---|
| Images | MR, SR | DICOM | Download requires NBIA Data Retriever |
20 | 142 | 264 | 4,608 | CC BY 4.0 |
| Standard Operating Procedure 50101: MRI T2 Weighted Non-Contrast Protocol: Single Mouse Pulmonary Gated and Multi-Mouse Non-Gated | Protocol | CC BY 4.0 | ||||||
| Standard Operating Procedure 50102: Positron Emission Tomography imaging protocol | Protocol | CC BY 4.0 |
Additional Resources for this Dataset
The National Cancer Institute (NCI) has developed a national repository of Patient-Derived Models (PDMs) comprised of patient-derived xenografts (PDXs), in vitro patient-derived tumor cell cultures (PDCs) and cancer associated fibroblasts (CAFs) as well as patient-derived organoids (PDOrg). These models serve as a resource for public-private partnerships and for academic drug discovery efforts. These PDMs are clinically-annotated with molecular information and made available in the Patient-Derived Model Repository. Data related to the specific subjects in this Collection can be found at:
The NCI Cancer Research Data Commons (CRDC) provides access to additional data and a cloud-based data science infrastructure that connects data sets with analytics tools to allow users to share, integrate, analyze, and visualize cancer research data.
- Imaging Data Commons (IDC) (Imaging Data)
Citations & Data Usage Policy
Data Citation Required: Users must abide by the TCIA Data Usage Policy and Restrictions. Attribution must include the following citation, including the Digital Object Identifier:
Data Citation |
|
|
Tatum, J., Kalen, J., Jacobs, P., Ileva, lilia, Riffle, L., Keita, S., Patel, N., Sanders, C., James, A., Difilippantonio, S., Thang, L., Hollingshead, M., Evrard, Y., Edmondson, E., Clunie, D., Liu, Y., Suloway, C., Smith, K., Wagner, U., Freymann, J. B., Kirby, J., Doroshow, J. (2022). Imaging characterization of a metastatic patient derived model of adenocarcinoma pancreas: (PDMR-521955-158-R4) (Version 1) [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/q37d-vh79 |
Acknowledgements
We would like to acknowledge the individuals and institutions that have provided data for this collection:
Frederick National Laboratory for Cancer Research – Special Thanks to Joseph D. Kalen, PhD, Lilia V. Ileva, MS, Lisa A Riffle, Nimit L Patel, MS, Keita Saito, PhD, Yvonne Evrard, PhD, Elijah Edmondson, DVM, PhD, Justin Smith, Simone Difilippantonio, PhD, Chelsea Sanders, Ulrike Wagner, Yanling Liu, PhD, John B. Freymann, and Justin Kirby.
Division of Cancer Therapeutics and Diagnosis/National Cancer Institute - James L. Tatum, MD, Paula M Jacobs, PhD, Melinda G. Hollingshead, DVM, and James H. Doroshow, MD
PixelMed Publishing – Special Thanks to David A. Clunie, MD
University of Arkansas for Medical Sciences – Special Thanks to Kirk E. Smith
- This project has been funded in whole or in part with Federal funds from the National Cancer Institution, National Institutes of Health, under Contract Number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.
Related Publications
Publications by the Dataset Authors
The authors recommended the following as the best source of additional information about this dataset:
No other publications were recommended by dataset authors.
Research Community Publications
TCIA maintains a list of publications that leveraged this dataset. If you have a manuscript you’d like to add please contact TCIA’s Helpdesk.